Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib

Total article views   Abstract views HTML views PDF downloads Totals
14,322 Dovepress* 12,147 1,135+ 1,746 13,282
PubMed Central* 0 1,040 326 1,040
Totals 12,147 2,175 2,072 14,322
*Since 5 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 0 0 1 8 9

View citations on PubMed Central and Google Scholar